Open AccessEmergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy
Author(s) -
AlKatib Ayad M.,
Gaith Hussein,
Sano Dahlia,
AlKatib Sayf,
Bonnett Michelle,
Kafri Zyad
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3019
Subject(s) - ibrutinib , medicine , chronic lymphocytic leukemia , multiple myeloma , oncology , leukemia , venetoclax
Ibrutinib is approved for chronic lymphocytic leukemia (CLL). However, its role in the treatment of multiple myeloma (MM) is not clear and is under investigation. We report a case of CLL that developed MM while on therapy with ibrutinib indicating that this drug may not be active against MM.